Systematic comparisons of electrocardiographic morphology increase the precision of QT interval measurement

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 1, 2009, Pages 119-130

  Hnatkova, Katerina ^a   Smetana, Peter ^b   Toman, Ondrej ^c   Bauer, Axel ^d   Schmidt, Georg ^d   Malik, Marek ^a  

^a St Paul's Cardiac Electrophysiology   (United Kingdom)

^b WILHELMINEN HOSPITAL   (Austria)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

ECG morphology; Pattern matching; QTc variability; Thorough QT QTc study

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; PARKINSON DISEASE; PATTERN RECOGNITION; POPULATION RESEARCH; QT INTERVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 58149177539     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02185.x     Document Type: Article

References (19)

1. E14 Clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Guidance to industry. Fed Regist 2005 70 : 61134 61135.
2. Sarapa N, Nickens DJ, Raber SR, Reynolds RR, Amantea MA. Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: A possible role as CYP3A inhibitor in thorough QTc studies. Clin Pharmacol Ther 2008 83 : 153 159.
3. Kubitza D, Mueck W, Becka M. Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation. Drug Safety 2008 31 : 67 77.
4. Hulhoven R, Rosillon D, Letiexhe M, Meeus MA, Daoust A, Stockis A. Levocetirizine does not prolong the QT/QTc interval in healthy subjects: Results from a thorough QT study. Eur J Clin Pharmacol 2007 63 : 1011 1017.
5. Malik M, Färbom P, Batchvarov V, Hnatkova K, Camm AJ. Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval. Heart 2002 87 : 220 228.
6. Batchvarov VN, Ghuran A, Smetana P, Hnatkova K, Harries M, Dilaveris P, Camm AJ, et al. QT-RR relationship in healthy subjects exhibits substantial inter-subject variability and high intra-subject stability. Am J Physiol Heart Circ Physiol 2002 282 : H2356 H2363.
7. Hnatkova K, Gang Y, Batchvarov VN, Malik M. Precision of QT interval measurement by advanced electrocardiographic equipment. Pacing Clin Electrophysiol 2006 29 : 1277 1284.
8. Batchvarov V, Hnatkova K, Malik M. Assessment of noise in digital electrocardiograms. Pacing Clin Electrophysiol 2002 25 : 499 503.
9. Daskalov IK, Dotsinsky IA, Christov II. Developments in ECG acquisition, preprocessing, parameter measurement, and recording. IEEE Eng Med Biol 1998 17 : 50 58.
10. Meyer CR, Keiser HN. Electrocardiogram baseline noise estimation and removal using cubic splines and state-space computation techniques. Comput Biomed Res 1977 10 : 459 470.
11. Pueyo E, Smetana P, Caminal P, de Luna AB, Malik M, Laguna P. Characterization of QT interval adaptation to RR interval changes and its use as a risk-stratifier of arrhythmic mortality in amiodarone-treated survivors of acute myocardial infarction. IEEE Trans Biomed Eng 2004 51 : 1511 1520.
12. Malik M. Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol 2001 12 : 411 420.
13. Fridericia LS. Die Systolendauer im Elekrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand 1920 53 : 469 486.
14. Zhang J, Machado SG. Statistical issues including design and sample size calculation in thorough QT/QTc studies. J Biopharm Stat 2008 18 : 451 467.
15. Zhang L, Dmitrienko A, Luta G. Sample size calculations in thorough QT studies. J Biopharm Stat 2008 18 : 468 482.
16. Malik M, Hnatkova K, Smetana P, Schmidt A. Accurately measured and heart-rate corrected QTc intervals do not show any day-time variability. (abstract) Eur Heart J 2007 28 : 624.
17. Rautaharju PM, Zhang ZM. Linearly scaled, rate-invariant normal limits for QT interval: Eight decades of incorrect application of power functions. J Cardiovasc Electrophysiol 2002 13 : 1211 1218.
18. Extramiana F, Maison-Blanche P, Badilini F, Pinoteau J, Deseo T, Coumel P. Circadian modulation of QT rate dependence in healthy volunteers: Gender and age differences. J Electrocardiol 1999 32 : 33 43.
19. Malik M, Andreas J-O, Hnatkova K, Hoeckendorff J, Cawello W, Middle M, Horstmann R, et al. Thorough QT/QTc study in patients with advanced Parkinson's disease - Cardiac safety of rotigotine. Clin Pharmacol Therap, in press.